跳至主要内容
临床试验/NCT00791024
NCT00791024已完成1 期

Phase One Study and Two of a New Method for Local Analgesia

Ove Andersen1 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
126
试验地点
1
主要终点
VAS score

研究概览

简要总结

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

详细描述

A phase one and two study. part one is performed as a single arm unblinded uncontrolled study in 16 obese patients undergoing awake intubation (investigational pill). The second part is a phase two study randomized single blinded study in 100 patient attending a day case endoscopy unit for oesophagogastroduodenoscopy (investigational pill versus lidocaine suspension).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted for adipositas surgery
  • Patients who attend for oesophagogastroduodenoscopy.

排除标准

  • Severe psychiatric diseases
  • Alcohol abuse

研究组 & 干预措施

single arm

Experimental

干预措施: CRC-Pharma 001 (Drug)

single arm

Experimental

干预措施: lidocaine suspension (Drug)

结局指标

主要结局

VAS score

时间窗: at day O and 3

次要结局

  • Questionnaire( examiner and patient)(performed at day 0 and 3)

研究者

发起方
Ove Andersen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ove Andersen

Research director

Hvidovre University Hospital

研究点 (1)

Loading locations...

相似试验